Skip to content
Investment Visual
/
Backtest
Tools
Browse
Stocks
MRNA
Financials
Revenue by region
MRNA
Moderna, Inc.
Backtest
MRNA
Overview
Returns
Financials
Holders
Insiders
Summary
Statements
Income
Revenue
Revenue by product
Revenue by region
Gross profit
Operating income
Net income
EPS
EBITDA
Cash flow
Balance sheet
Valuation
Shares and dividends
Costs
Revenue by region
Annual
Quarterly
Revenue by region
Annual
Quarterly
2025, ended Dec 31, 2025
United States
$1.2B
62%
Rest of world
$692M
36%
Europe
$53M
3%
Regions by fiscal year
CSV
Regions by fiscal year
USD
Line, in USD
2025
2024
2023
2022
2021
2020
2019
2018
United States
1.20B
1.79B
1.90B
5.15B
6.18B
0.76B
55M
89M
Europe
53M
0.60B
1.36B
6.82B
6.85B
33M
5.0M
—
Rest of world
0.69B
0.85B
3.60B
7.30B
5.45B
6.0M
—
46M
Total
1.9B
3.2B
6.8B
19.3B
18.5B
803M
60M
135M
More Moderna financials
Revenue
Revenue by product
Gross profit
Operating income
Net income
EPS
Revenue at other companies
LLY
Eli Lilly and Company
UNH
UnitedHealth Group Incorporated
JNJ
Johnson & Johnson
MDT
Medtronic plc
TMO
Thermo Fisher Scientific Inc.
ABBV
AbbVie Inc.
Tools
Return calculator